Disease Info Card

Bronchiolitis Obliterans

Information about Bronchiolitis Obliterans: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Bronchiolitis Obliterans

Most recent studies have shown that Bronchiolitis Obliterans shares some biological mechanisms with airway-disease, bronchiectasis, bronchiolitis, bronchiolitis-obliterans-organizing-pneumonia, coughing, cystic-fibrosis, cytomegalovirus-infections, decreased-immunologic-activity-[pe], dyspnea, fibrosis, graft-vs-host-disease, infective-disorder, inflammation, lung-diseases, lung-diseases-obstructive, malignant-neoplasms, organising-pneumonia, pneumonia, pneumonia-interstitial, pulmonary-fibrosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Bronchiolitis Obliterans, and have been seen in publications frequently: Angiogenesis, Cell Proliferation, Chemotaxis, Complement Activation, Cytokine Production, Dehiscence, Donor Selection, Epithelial To Mesenchymal Transition, Fibroblast Proliferation, Gastric Emptying, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Pathogenesis, Regeneration, Secretion, Sensitization, Tissue Remodeling, Wound Healing

Quite a number of genes have been found to play important roles in Bronchiolitis Obliterans, such as AKR1B1, AR, AREG, CCL2, CD4, CD8A, CDH11, CTLA4, FDXR, FEV, HLA-DQA1, HLA-DRB4, IL10, IL2, IL6, LEP, NOD2, SCGB1A1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.